Neuropharmagen® is a genetic test, developed by AB Biotics, Spain, for use in neurology and psychiatry that identifies the safest and most appropriate medication for each individual patient by analyzing their DNA.
Neuropharmagen® is a breakthrough in pharmacogenetics. It provides the most extensive genetic-based information on drug efficacy, metabolism and adverse effects. The test helps reduce the time spent identifying the most effective treatment choices for each patient. This allows positive clinical outcome and better quality of life for patients.
Neuropharmagen® provides information about:
- Drug Response: Indicates the likelihood of positive or negative response to individual drugs, depending on the patient´s genetic profile
- Adverse Reactions: Indicates whether the patient has a higher-than-average risk of experiencing adverse effects when treated with particular drugs
- Dose: Provides information about the genetic factors that control activation, distribution and clearance of some drugs, thus helping to identify the most appropriate dose for the patient
The test is typically performed by a saliva sample. The test kit includes all the material and documents to order the test and collect the sample. The Neuropharmagen® test report contains specialized information that requires the interpretation of a medical professional. Therefore any test request must be signed by a physician.
Results are available within 2 weeks.
For more information about Neuropharmagen®, please visit:
Neuropharmagen® is commercially available in the GCC countries, Lebanon and Egypt.
For further information related to the product and its availability in your country of residence, please contact us at:
Phone: +971 4 4227010
For more information about the collaboration between Genpharm and AB Biotics, please visit our news section.